FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration...
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
CDC warns that RSV cases may be starting to rise | CNN
Sep 5, 2023 · The US Centers for Disease Control and Prevention is warning physicians that cases of respiratory syncytial virus, known as RSV, are rising in the Southeast — and that regional increase may...
Federal Officials Revise Recommendations for R.S.V. Vaccine
Jun 26, 2024 · In an unusual move, federal health officials revised their recommendations for who should receive the vaccine against the respiratory syncytial virus.
FDA advisers recommend world's first RSV vaccines, from ... - NBC News
Mar 1, 2023 · On Tuesday, the Independent Vaccines and Related Biological Products Advisory Committee voted 7-4 to recommend Pfizer's vaccine based on its efficacy, with one abstention. The single-dose shot was...
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults …
Oct 22, 2024 · ABRYSVO now offers the broadest RSV vaccine indication for adults, which previously included those 60 years and older. Additionally, it remains the only RSV immunization approved for pregnant individuals at 32 through 36 weeks of gestation to protect infants from birth up to 6 months of age.
Surge in cases of RSV, a virus that can severely sicken ... - NBC News
Hospitals across the country have reported a surge in RSV cases over the last three to four weeks. The virus began circulating in the summer, to doctors' surprise, since it usually peaks in...
RSV: What to know about the latest surge and treatments : NPR
Nov 2, 2022 · Here are answers to some of the most common questions about the RSV infection, who is most at risk and what might be causing this year's outbreak. Why might RSV be particularly bad this year?
FDA approves Pfizer's RSV vaccine for adults at increased risk of …
Oct 22, 2024 · The U.S. Food and Drug Administration on Tuesday approved Pfizer 's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of...
Progress at last against RSV - Nature Medicine
Sep 14, 2023 · A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in northern climes, has strained ...